Clinical Trials Logo

Nervous System Diseases clinical trials

View clinical trials related to Nervous System Diseases.

Filter by:

NCT ID: NCT04266743 Completed - Stroke Clinical Trials

FeetMe® Monitor: Alternative for the Evaluation of Gait Speed After Stroke

Start date: October 29, 2018
Phase: N/A
Study type: Interventional

The aim of this study is to validate a smart insoles system in comparison to the gold-standard GaitRite for a pathologic gait. The device evaluate gait parameters in real time thanks to an embedded algorithm based on the processing of inertial measurement unit and 19 sensors signals. At D0 and D7, the patient is evaluated by both the GaitRite® system and the FeetMe Monitor® system simultaneously. Hemiparetic patients have two measurements 7 days apart. The patient repeats 5 trials at a comfortable speed on the GaitRite® mat while wearing the FeetMe® insoles. Each measurement is repeated by 4 different operators. A total of 20 trials are made by the patient.

NCT ID: NCT04266639 Completed - Ischemic Stroke Clinical Trials

Rheo-Erythrocrine Dysfunction as a Biomarker for RIC Treatment in Acute Ischemic Stroke

ENOS
Start date: July 29, 2020
Phase: N/A
Study type: Interventional

This study aims to investigate whether Remote Ischemic Conditioning (RIC) improves rheo-erythrocrine dysfunction in acute ischemic stroke

NCT ID: NCT04265664 Completed - Stroke Clinical Trials

Telerehabilitation With Aims to Improve Lower Extremity Recovery Post-Stroke

TRAIL
Start date: July 28, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the feasibility and effectiveness of a lower extremity telerehabilitation protocol with aims to improve lower extremity recovery among community-living stroke survivors across Canada.

NCT ID: NCT04260035 Completed - Pain Clinical Trials

The Effects of a Long-lasting Infusion of Vasoactive Intestinal Peptide (VIP) in Episodic Migraine Patients

Start date: May 19, 2020
Phase: N/A
Study type: Interventional

Vasoactive intestinal peptide (VIP) is a peptide of 28 amino acid residues that belongs to the glucagon/secretin superfamily of peptides. Along with other neuropeptides, such as calcitonin gene-related peptide (CGRP) and pituitary adenylate cyclase-activating polypeptide (PACAP), it is released from the trigeminal afferents and exerts a strong vasodilating activity on the cranial vasculature. Especially, it shares 70% structure with PACAP and acts on the same receptors. But, unlike it, VIP cannot induce a long-lasting vasodilation and has a modest capability to induce migraine attacks. Whether it may induce migraine-like attacks in migraine patients, as a twenty-minute infusion of PACAP, is unknown.

NCT ID: NCT04259151 Completed - Clinical trials for Neurological Disorder

Evaluation on Standardized Circuits of the Interest of a Robotic Module of Assistance to the Driving

SWADAPT2
Start date: June 25, 2020
Phase: N/A
Study type: Interventional

The device that is the subject of this investigation is a robotic assistance module for driving a semi-autonomous electric wheelchair. This module is designed to accessorize the electric wheelchair to improve the safety conditions when driving an electric wheelchair, thus reducing the wheelchair accident rate on the one hand and facilitating access to the wheelchair to persons who can not claim it without the use of a safety device of this type.

NCT ID: NCT04255212 Completed - Muscle Strength Clinical Trials

Effects of Soft Tissue Treatment vs Mechanisms Explanation to Treat Delayed Onset Muscles Soreness Among Sport Climbers

Start date: January 13, 2020
Phase: N/A
Study type: Interventional

The aim of the present research is to define the effects of short manual treatment of soft tissues compared to mechanisms explaining in Delayed Onset Muscle Soreness (DOMS) among sport climbers and to address the mechanisms of peripheral and central sensitization involved in DOMS phenomena.

NCT ID: NCT04240275 Completed - Clinical trials for Gait Disorders, Neurologic

Reliability of a Body-worn Sensor System for Gait Analysis in Children With CP

Start date: June 3, 2019
Phase:
Study type: Observational

Cerebral palsy (CP) is caused by a non‐progressive injury in the developing brain, which leads to problems in functional mobility, posture, neuro musculoskeletal functions and gait. Around 75% of children with CP are ambulatory however they have gait problems such as excessive knee flexion, stiff knee, crouch gait or equinus which affects the quality of gait. When constructing an effective treatment plan in children with CP, a comprehensive assessment should be performed. One of the most essential assessments is gait analysis. Gait analysis is used in the quantitative assessment of gait disturbances providing functional diagnosis, assessment for treatment, planning, and monitoring of progress. Gait analysis aims to determine the factors leading to gait disturbances. To reach this aim, a large amount of quantitative data concerning the gait characteristics of a patient is analyzed. The assessment of these data can be performed via standardized clinical videos, recorded with numerical video cameras used in conjunction with optical 3D systems. The purpose of this study was to confirm the test-retest reliability of a commercially available body-worn sensor— G-Walk® sensor system—for spatiotemporal gait parameters in children with CP.

NCT ID: NCT04235465 Completed - Clinical trials for Gait Disorders, Neurologic

Dynamic Gait Index in Children With Dyslexia

Start date: April 2, 2018
Phase:
Study type: Observational

The aim of the present study is to investigate reliability in dyslexic children and compare it with healthy peers.

NCT ID: NCT04232163 Completed - Stroke Clinical Trials

Arm Boot Camp Study: Evaluation of a Program to Increase Upper Limb Recovery After Stroke

Start date: August 15, 2020
Phase: N/A
Study type: Interventional

This study will examine the feasibility and effect of a program that combines exercise and feedback from a wearable device on upper limb movement practice and function in individuals with stroke.

NCT ID: NCT04220606 Completed - Migraine Disorders Clinical Trials

1H Magnetic Resonance Spectroscopy in Migraine Patients

Start date: April 2015
Phase: N/A
Study type: Interventional

To investigate the glutaminergic system in the onset of migraine-like attacks.